Skip to main content


Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis

Fig. 1

Human PBMCs treated with liraglutide. Human PBMCs were co-treated with LPS 1 μg/ml and liraglutide 1 μmol/l for 2 h. Cells were analyzed for a and c TNF-alpha and b and d MCP-1 by a, b RT-qPCR and c, d ELISA. Error bars are representative of cells from three healthy volunteers (n = 3). Statistical analysis was carried out performing a Kruskal–Wallis test followed by Dunn’s multiple comparison post-test. Statistical significance was considered when *p < 0.05. Non-significance (NS) was considered when p > 0.05. Capped lines indicate comparisons made between groups which are of statistical significance

Back to article page